ScreenerHero
IDXXIDEXX Laboratories, Inc.
NAS · US · Healthcare · Diagnostics & Research · idexx.com
552.91USD-1.65%Mkt Cap: 44.35B $P/E: 39.54

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It opera…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8

Key Statistics

Company
Market Cap44.35B $
Enterprise Value43.90B $
Revenue (TTM)4.55B $
Gross Profit2.66B $
Net Income (TTM)1.06B $
Revenue/Share57.17 USD
Last Price552.91 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS45168D1046
Valuation
P/E (Trailing)39.54
P/E (Forward)32.61
PEG3.44
EV/EBITDA27.07
EV/Revenue9.64
P/S9.44
P/B26.70
EPS (TTM)13.81
EPS (Forward)16.74
52W Range
518.5514% of range769.98
52W High769.98 USD
52W Low518.55 USD
Profitability
Gross Margin61.80%
Oper. Margin34.98%
EBITDA Margin35.62%
Profit Margin24.62%
ROE65.99%
ROA31.62%
Growth
Revenue Growth9.70%
Earnings Growth17.60%
Cash Flow & Leverage
Operating CF1.18B $
CapEx (TTM)138.23M $
FCF Margin19.97%
FCF Yield2.05%
Net Debt899.15M $
Net Debt/EBITDA0.55
Balance Sheet
Debt/Equity0.61
Current Ratio1.17
Quick Ratio0.73
Book Value/Sh20.45 USD
Cash/Share2.500 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJun 16, 2015
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)698.92 USD
Upside (mean)+26.4%
Target Range470.00 USD – 805.00 USD
$470.00+26.4% to mean$805.00
# Analysts13
Ownership
Shares Out.78.88M
Float78.50M
Insiders0.22%
Institutions96.84%
Short Interest
Short Ratio3.2d
Short % Float2.80%
Short % Out.2.45%
Shares Short1.93M
Short (prev mo.)1.94M
Technical
SMA 50560.00 (-1.3%)
SMA 200615.93 (-10.2%)
Beta1.54
S&P 52W Chg18.16%
Avg Vol (30d)585.90K
Avg Vol (10d)552.93K
Technical Indicators
RSI (14)48.5
MACD0.9161
MACD Signal4.0011
MACD Hist.-3.0851
BB Upper601.40 USD
BB Middle566.93 USD
BB Lower532.46 USD
BB Width12.16%
ATR (14)19.94 USD
Vol Ratio (20d)0.78x